Ixazomib, Daratumumab and Low Dose Dexamethasone in Intermediate-Fit Patients with Newly Diagnosed Multiple Myeloma (NDMM); Results of Induction Treatment of the Phase II HOVON 143 Study
Resource Type
Article
Authors
Groen, Kaz ; Stege, Claudia A.M. ; Nasserinejad, Kazem ; de Heer, Koen ; Van Kampen, Roel J.W. ; Leijs, Maria B.L. ; Thielen, Noortje ; Westerman, Matthijs ; Wu, Ka Lung ; Ludwig, Inge ; Issa, Djamila ; Velders, Gerjo A. ; Vekemans, Marie-Christiane ; van de Donk, Niels W.C.J. ; Timmers, Gert-Jan ; Sonneveld, Pieter ; Seefat, Maarten R. ; Croon-de Boer, Fransien ; Tick, Lidwine W. ; van der Spek, Ellen ; De Waal, Esther G.M. ; Sohne, Maaike ; Ypma, Paula F ; Nijhof, Inger S. ; Klein, Saskia K. ; Levin, Mark-David ; Zweegman, Sonja
Source
Blood; November 2021, Vol. 138 Issue: 1, Number 1 Supplement 1 p80-80, 1p
Subject
Language
ISSN
00064971; 15280020